UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015893
Receipt No. R000016520
Scientific Title exploratory study for children severe cardiomyopathy using YS0001
Date of disclosure of the study information 2015/05/01
Last modified on 2019/05/07 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title exploratory study for children severe cardiomyopathy using YS0001
Acronym exploratory study for children severe cardiomyopathy using YS0001
Scientific Title exploratory study for children severe cardiomyopathy using YS0001
Scientific Title:Acronym exploratory study for children severe cardiomyopathy using YS0001
Region
Japan

Condition
Condition Severe Cardiomyopathy in Pediatric patietns
Classification by specialty
Cardiology Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Safety and efficacy study of autologous myoblast sheet for children
Severe cardiomyopasthy
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Primary endopoint is to assess the safty
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Culture of autologous skeletal myoblasts and engineering myoblast sheets. Transplantation of myoblast sheets to heart
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
18 years-old >=
Gender Male and Female
Key inclusion criteria Severe myopathy
NYHA Class iii
Ejection fraction =<35%]
Key exclusion criteria Cardiomyopathy without other surgical options persisitent NYHA Class =>iii HF symptoms refractory to maximal medical therapy Ejection fraction =<35%
Target sample size 3

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Yoshiki Sawa
Organization Osaka University hospital
Division name Cardiovascular Surgery
Zip code
Address 2-15 Yamadaoka Suita Osaka Japan
TEL 06-6879-3154
Email sawa@surg1.med.osaka-u.ac.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Masaki Taira
Organization Osaka University hospital
Division name Cardiovascular Surgery
Zip code
Address 2-15 Yamadaoka Suita Osaka Japan
TEL 06-6879-3154
Homepage URL
Email taira@surg1.med.osaka-u.ac.jp

Sponsor
Institute Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University
Institute
Department

Funding Source
Organization Japan Agency for medical research and development
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 05 Month 01 Day
Date of IRB
2016 Year 02 Month 05 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
2018 Year 10 Month 12 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 12 Month 10 Day
Last modified on
2019 Year 05 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016520